RD
Ryan Deschner Raymond James Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Liquidia Corp
LQDA
$2.41B
| $27.98 | $41 |
47%
upside
| Strong Buy |
13 Aug ‘25
26 days ago |
|
2
Trevi Therapeutics
TRVI
$926M
| $7.60 | $27 |
255%
upside
| Strong Buy |
8 Aug ‘25
1 month ago |
|
|
PVLA
3
Palvella Therapeutics, Inc. Common Stock
PVLA
$609M
| $55.02 | $54 |
2%
downside
| Outperform |
6 Aug ‘25
1 month ago |
|
4
Ardelyx
ARDX
$1.59B
| $6.59 | $12 |
82%
upside
| Outperform |
5 Aug ‘25
1 month ago |
|
5
Apellis Pharmaceuticals
APLS
$3.4B
| $26.91 | $50 |
86%
upside
| Outperform |
1 Aug ‘25
1 month ago |
|
6
Viking Therapeutics
VKTX
$2.87B
| $25.48 | $122 |
379%
upside
| Strong Buy |
24 Jul ‘25
1 month ago |
|
|
TVRD
7
Tvardi Therapeutics, Inc. Common Stock
TVRD
$278M
| $29.66 | $62 |
109%
upside
| Outperform |
14 Jul ‘25
1 month ago |
|
8
ARS Pharmaceuticals
SPRY
$1.06B
| $10.70 | $28 |
162%
upside
| Strong Buy |
14 Jan ‘25
7 months ago |
|